Steve Valiquette
Stock Analyst at Barclays
(1.54)
# 3,402
Out of 5,182 analysts
147
Total ratings
48.08%
Success rate
-1.59%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $8 → $9.5 | $14.32 | -33.66% | 6 | Nov 10, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $6.46 | +85.76% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $814.02 | -24.33% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $2.55 | +252.94% | 7 | Mar 1, 2024 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $19.25 | +24.68% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $82.09 | +4.76% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $53.34 | +59.36% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $433.09 | -30.73% | 4 | Jun 28, 2023 | |
| LTC LTC Properties | Maintains: Underweight | $35 → $34 | $38.50 | -11.69% | 3 | May 3, 2023 | |
| THC Tenet Healthcare | Maintains: Overweight | $70 → $105 | $183.27 | -42.71% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $88.02 | -37.51% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $20.36 | -36.15% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $167.00 | -14.97% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $37.47 | -86.66% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $107.48 | -46.97% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $216.91 | -62.20% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $16.42 | +9.62% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $46.98 | -34.01% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $192.70 | +94.60% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $39.19 | -51.52% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $233.63 | +143.98% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $195.24 | -67.22% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $282.90 | +9.58% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $368.78 | +53.21% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $1.11 | +6,656.76% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $8.32 | +128.37% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $2.98 | +235.57% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $6.61 | +202.57% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $78.31 | +232.01% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $8 → $9.5
Current: $14.32
Upside: -33.66%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $6.46
Upside: +85.76%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $814.02
Upside: -24.33%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $2.55
Upside: +252.94%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $19.25
Upside: +24.68%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $82.09
Upside: +4.76%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $53.34
Upside: +59.36%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $433.09
Upside: -30.73%
LTC Properties
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $38.50
Upside: -11.69%
Tenet Healthcare
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $183.27
Upside: -42.71%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $88.02
Upside: -37.51%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $20.36
Upside: -36.15%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $167.00
Upside: -14.97%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $37.47
Upside: -86.66%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $107.48
Upside: -46.97%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $216.91
Upside: -62.20%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $16.42
Upside: +9.62%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $46.98
Upside: -34.01%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $192.70
Upside: +94.60%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $39.19
Upside: -51.52%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $233.63
Upside: +143.98%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $195.24
Upside: -67.22%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $282.90
Upside: +9.58%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $368.78
Upside: +53.21%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $1.11
Upside: +6,656.76%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $8.32
Upside: +128.37%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $2.98
Upside: +235.57%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $6.61
Upside: +202.57%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $78.31
Upside: +232.01%